June 14, 2005
ON THE MOVE
Alex Kotzer will join Compugen as president and CEO on September 1, after his relocation to Israel. Kotzer, whose most recent position was VP of Serono, will replace current president and CEO Mor Amitai, Ph.D., who announced last October that he intends to resign from these positions before the end of 2005.
CHANGE OF GUARD
Stephen P. DeFalco, chairman and CEO of U.S. Genomics, has joined MDS Inc. as COO and will succeed John Rogers, who plans to retire by the end of 2005, as president and CEO. DeFalco will remain on the U.S. Genomics Board.
A FUNDING FIND
Mitsui USA has invested $5 million in Gentris. The funding, announced one month after the FDA issued guidance on pharmacogenomic data submissions, will help Gentris deliver on its promise of personalized medicine and proceed with its plan to develop and distribute pharmacogenomic diagnostic testing kits.
454 Life Sciences and Roche announce their entry into an exclusive, 5-year, worldwide agreement for the promotion, sale, and distribution of 454 Life Sciences' nanotechnology-based genome sequencing systems, including proprietary kits and reagents.